TScan Therapeutics Expands Manufacturing Leadership with the Appointment of Justin McCue, Ph.D., as Chief Technology Officer
Position
Chief Technology Officer
Company
TScan Therapeutics, Inc.
WalthamBiotechnologyHealth CareMedicalTherapeuticsDescription
TScan Therapeutics Inc, a clinical-stage biopharmaceutical company focused on the development of T cell receptor -engineered T cell therapies for the treatment of patients with cancer, today announced the appointment of Justin McCue, Ph.D., as its Chief Technology Officer.
Quick answer
TScan Therapeutics Expands Manufacturing Leadership with the Appointment of Justin McCue, Ph.D., as Chief Technology Officer (December 4, 2023). TScan Therapeutics, Inc. is based in Waltham, Massachusetts, United States.
- Who is the new Chief Technology Officer at TScan Therapeutics, Inc?
- TScan Therapeutics, Inc. named Justin McCue Chief Technology Officer, announced December 4, 2023.
- What did TScan Therapeutics, Inc. announce on December 4, 2023?
- TScan Therapeutics Inc, a clinical-stage biopharmaceutical company focused on the development of T cell receptor -engineered T cell therapies for the treatment of patients with cancer, today announced the appointment of Justin McCue, Ph.D., as its Chief Technology Officer.
- What does TScan Therapeutics, Inc. do?
- TScan Therapeutics is an experienced group of scientists, development specialists, and other leaders driving a cutting edge platform
- Where is TScan Therapeutics, Inc. based?
- TScan Therapeutics, Inc. is based in Waltham, Massachusetts, United States.
- Which similar companies made leadership changes around the same time?
- Smart Immune (December 4, 2023), Myeloid (December 6, 2023), NYU Langone Health (December 1, 2023) and Diakonos Oncology (November 20, 2023) also announced leadership changes within 45 days of TScan Therapeutics, Inc.
Source: Fundz verified event record.
Other recent leadership changes in Medical and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Smart Immune appoints Dr. Rahim Fandi, M.D, PhD as Chief Medical Officer, strengthening C suite with seasoned oncology expertise (December 4, 2023)
- Myeloid Announces Appointment of Matthew Maurer, M.D. as Chief Medical Officer (December 6, 2023)
- NYU Langone Hospital--Long Island Appoints Mario E. Lacouture, MD, as the New Chief of Dermatology (December 1, 2023)
- Diakonos Oncology Names Ian H. Bellayr, Ph.D. Chief Regulatory Officer (November 20, 2023)
- Aethlon Medical Announces Appointment of James B. Frakes, M.B.A. as Interim Chief Executive Officer and Guy Cipriani, M.B.A. as Chief Operating Officer (November 13, 2023)
- Incendia Therapeutics Appoints Wendye Robbins, M.D., as Chief Executive Officer and Doses First Patient in Phase 1b Clinical Trial of PRTH-101, a Novel DDR1 Inhibitor (November 13, 2023)
Who to call at TScan Therapeutics, Inc., and when
A new leader at TScan Therapeutics, Inc. brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day TScan Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at TScan Therapeutics, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at TScan Therapeutics, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment TScan Therapeutics, Inc. changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
TScan Therapeutics, Inc. changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.